Zobrazeno 1 - 10
of 295
pro vyhledávání: '"Loris De Cecco"'
Autor:
Michele Sommariva, Maria Dolci, Tiziana Triulzi, Federico Ambrogi, Matteo Dugo, Loris De Cecco, Valentino Le Noci, Giancarla Bernardo, Martina Anselmi, Elena Montanari, Serenella M. Pupa, Lucia Signorini, Nicoletta Gagliano, Lucia Sfondrini, Serena Delbue, Elda Tagliabue
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-15 (2024)
Abstract The pandemic of coronavirus disease 19 (COVID-19), caused by severe respiratory syndrome coronavirus 2 (SARS-CoV-2), had severe repercussions for breast cancer patients. Increasing evidence indicates that SARS-CoV-2 infection may directly im
Externí odkaz:
https://doaj.org/article/f4deb679c2c240ba9be7164d7699b246
Autor:
Serena Di Cosimo, Sara Pizzamiglio, Chiara Maura Ciniselli, Valeria Duroni, Vera Cappelletti, Loris De Cecco, Cinzia De Marco, Marco Silvestri, Maria Carmen De Santis, Andrea Vingiani, Biagio Paolini, Rosaria Orlandi, Marilena Valeria Iorio, Giancarlo Pruneri, Paolo Verderio
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract In clinical trials evaluating antibody-conjugated drugs (ADCs), HER2-low breast cancer is defined through protein immunohistochemistry scoring (IHC) 1+ or 2+ without gene amplification. However, in daily practice, the accuracy of IHC is comp
Externí odkaz:
https://doaj.org/article/d7df224a01ee4e5988733bfc39acbfb0
Autor:
Adele Busico, Monica Rodolfo, Lorenza Di Guardo, Michele Del Vecchio, Licia Rivoltini, Laura Bergamaschi, Viviana Vallacchi, Mario Santinami, Elisabetta Vergani, Mara Cossa, Chiara Gargiuli, Andrea Devecchi, Matteo Dugo, Loris De Cecco, Stefano Cavalieri, Barbara Valeri, Elena Tamborini, Gianfrancesco Gallino, Marialuisa Sensi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 1 (2024)
Durable remissions are observed in 10%–20% of treated patients with advanced metastatic melanoma but the factors associated with long-term complete clinical responses are largely unknown. Here, we report the molecular characteristics of tumor evolu
Externí odkaz:
https://doaj.org/article/6ee6e9735e44433696b169cef2b40458
Autor:
Nerina Denaro, Lisa Licitra, Marco Merlano, Francesco Perri, Paolo Bossi, Cristina Gurizzan, Federica Perrone, Athanassios Argiris, Loris De Cecco, Stefano Cavalieri, Mara Serena Serafini, Federico Pistore, Deborah Lenoci, Silvana Canevari, Mario Airoldi, Maria Cossu Rocca, Primoz Strojan, Cvetka Grasic Kuhar, Andrea Vingiani, Maria Grazia Ghi, Alessandra Cassano, Giacomo Allegrini
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 1 (2024)
Background Immune checkpoint inhibitors have been approved and currently used in the clinical management of recurrent and metastatic head and neck squamous cell carcinoma (R/M HNSCC) patients. The reported benefit in clinical trials is variable and h
Externí odkaz:
https://doaj.org/article/b9740be0719d4304a7e872232992bfd0
Autor:
Stefano Cavalieri, Eleonora Bruno, Mara Serena Serafini, Deborah Lenoci, Silvana Canevari, Laura Lopez-Perez, Liss Hernandez, Luigi Mariani, Rosalba Miceli, Cecilia Gavazzi, Patrizia Pasanisi, Elena Rosso, Francesca Cordero, Paolo Bossi, Wojciech Golusinski, Andreas Dietz, Primož Strojan, Thorsten Fuereder, Loris De Cecco, Lisa Licitra
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
BackgroundThere is a strong need for preventive approaches to reduce the incidence of recurrence, second cancers, and late toxicities in head and neck squamous cell carcinoma (HNSCC) survivors. We conducted a randomized controlled trial (RCT) to asse
Externí odkaz:
https://doaj.org/article/6ddb8c97126d47debcf457fefba9d6d1
Autor:
Anna Corti, Loris De Cecco, Stefano Cavalieri, Deborah Lenoci, Federico Pistore, Giuseppina Calareso, Davide Mattavelli, Pim de Graaf, C. René Leemans, Ruud H. Brakenhoff, Marco Ravanelli, Tito Poli, Lisa Licitra, Valentina Corino, Luca Mainardi
Publikováno v:
Biomarker Research, Vol 11, Iss 1, Pp 1-14 (2023)
Abstract Background . At present, the prognostic prediction in advanced oral cavity squamous cell carcinoma (OCSCC) is based on the tumor-node-metastasis (TNM) staging system, and the most used imaging modality in these patients is magnetic resonance
Externí odkaz:
https://doaj.org/article/70e9ed0a5e974d13933a26dc8dbdbbf4
Autor:
Luca Forlani, Loris De Cecco, Vittorio Simeon, Biagio Paolini, Marina Bagnoli, Sabrina Chiara Cecere, Anna Spina, Eleonora Citeroni, Eliana Bignotti, Domenica Lorusso, Laura Arenare, Daniela Russo, Carmine De Angelis, Laura Ardighieri, Giosuè Scognamiglio, Michele Del Sesto, Germana Tognon, Daniela Califano, Clorinda Schettino, Paolo Chiodini, Francesco Perrone, Delia Mezzanzanica, Sandro Pignata, Antonella Tomassetti
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-17 (2023)
Abstract Background Validated prognostic biomarkers for anti-angiogenic therapy using the anti-VEGF antibody Bevacizumab in ovarian cancer (OC) patients are still an unmet clinical need. The EGFR can contribute to cancer-associated biological mechani
Externí odkaz:
https://doaj.org/article/218fe5829cc64926a70c90f947c39308
Autor:
Emanuela Minna, Andrea Devecchi, Federico Pistore, Biagio Paolini, Giuseppe Mauro, Donata Alda Penso, Sonia Pagliardini, Adele Busico, Giancarlo Pruneri, Loris De Cecco, Maria Grazia Borrello, Marialuisa Sensi, Angela Greco
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
BackgroundPapillary thyroid carcinoma (PTC) is the most common type of thyroid cancer (TC). Several genomic and transcriptomic studies explored the molecular landscape of follicular cell-derived TCs, and BRAFV600E, RAS mutations, and gene fusions are
Externí odkaz:
https://doaj.org/article/a2ba787322b94a97926f10f8def11ee5
Autor:
Cosimo Cumbo, Paola Orsini, Luisa Anelli, Antonella Zagaria, Maria Federica Iannò, Loris De Cecco, Crescenzio Francesco Minervini, Nicoletta Coccaro, Giuseppina Tota, Elisa Parciante, Maria Rosa Conserva, Immacolata Redavid, Francesco Tarantini, Angela Minervini, Paola Carluccio, Anna De Grassi, Ciro Leonardo Pierri, Giorgina Specchia, Pellegrino Musto, Francesco Albano
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
DNMT3A gene mutations, detected in 20-25% of de novo acute myeloid leukemia (AML) patients, are typically heterozygous. Biallelic variants are uncommon, affecting ~3% of cases and identifying a worse prognosis. Indeed, two concomitant DNMT3A mutation
Externí odkaz:
https://doaj.org/article/67304e13084e4bf5b6a67403eb0762c3
Autor:
Sara Ciceri, Andrea Carenzo, Maria Federica Iannó, Alessia Bertolotti, Carlo Morosi, Roberto Luksch, Filippo Spreafico, Paola Collini, Paolo Radice, Maura Massimino, Loris De Cecco, Daniela Perotti
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Intra-tumor heterogeneity (ITH) fosters tumor evolution, resistance to therapy, and relapse. Recently, many evidence have been accumulated on the occurrence of genetic ITH in pediatric cancers. With this study we aimed to address the downstr
Externí odkaz:
https://doaj.org/article/433b0d4ecf2249d2baa958198befd2d2